MR results demonstrated that increased expression of the SPATS2L gene was associated with reduced AF risk (odds ratio [OR] = 0.874; 95% confidence interval [CI], 0.842–0.907; p = 1.41 × 10−12). Here, SPATS2L is linked to atrial fibrillation.